Genomic Valley Biotech Ltd. BSE: 539206

Download real time

41.74 -3.34 (-7.41%)

New 52W Low in past week

18,036

BSE Volume

High volume+loss today

BSE 29 Aug, 2025 3:31 PM (IST)

Genomic Valley Biotech Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Genomic Valley Biotech Ltd. on BSE

Search Inside the pdf :

Genomic Valley Biotech Ltd.

09 Aug 2025

41.74

-7.41%

Company Update

Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Advertisement regarding publication of unaudited financial result of the company for the quarter ended 30 June, 2025.

Genomic Valley Biotech Ltd.

07 Aug 2025

41.74

-7.41%

Company Update

Genomic Valley Biotech Ltd - 539206 - Re-Appointment Of Mr. Yogesh Agrawal As Chairman & Managing …

BSE India

Re-appointment of Mr. Yogesh Agrawal as Chairman & Managing Director of the Company for the period of five (5) years with effect from 07.09.2025.

Genomic Valley Biotech Ltd.

07 Aug 2025

41.74

-7.41%

Company Update

Genomic Valley Biotech Ltd - 539206 - Appointment Of Internal Auditor For The FY 2025-26.

BSE India

Considered and approved the appointment of Mr. Navjyoti Kumar Jha as internal auditor of the company for the FY 2025-26.

Genomic Valley Biotech Ltd.

07 Aug 2025

41.74

-7.41%

Company Update

Genomic Valley Biotech Ltd - 539206 - Appointment Of Secretarial Auditor

BSE India

Appointment of M/s SBR & Co. LLP, Company Secretaries (LLP No. AA0-9057) as Secretarial auditors of the company for the FY 2025-2030.

Genomic Valley Biotech Ltd.

07 Aug 2025

41.74

-7.41%

Result

Genomic Valley Biotech Ltd - 539206 - Unaudited Financial Results For Quarter Ended June 30, 2025.

BSE India

Considered and approve the unaudited financial results for the quarter ended June 30, 2025 along with limited review report.

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	0.09	0.26	0.16	-65.4%	-43.8%
Operating Profit Qtr	0.03	0.00	0.13	-	-76.9%
Net Profit Qtr	0.02	-0.08	0.13	125.0%	-84.6%
Earning Per Share Adjusted latest Qtr	0.08	-0.27	0.42	129.6%	-81.0%

* Standalone data

Detailed Results

Genomic Valley Biotech Ltd.

07 Aug 2025

41.74

-7.41%

Result

Genomic Valley Biotech Ltd - 539206 - Board Meeting Outcome for Outcome Of The Board Meeting …

BSE India

1. Considered and approved the Un-audited financial results of the company for the quarter ended 30th June 2025. 2. Appointment of M/s. SBR & Co. LLP, Company Secretaries (LLP No. AAO-9057) as the Secretarial Auditors of the Company for Financial year 25-30. 3. Considered and approved the appointment of Mr. Navjyoti Kumar Jha as Internal Auditor of the company for the F.Y. 2025-26. 4. Re-appointment of Mr. Yogesh Agrawal as Chairman & Managing Director of the Company for the period of five (5) years with effect from 07.09.2025.

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	0.09	0.26	0.16	-65.4%	-43.8%
Operating Profit Qtr	0.03	0.00	0.13	-	-76.9%
Net Profit Qtr	0.02	-0.08	0.13	125.0%	-84.6%
Earning Per Share Adjusted latest Qtr	0.08	-0.27	0.42	129.6%	-81.0%

* Standalone data

Detailed Results

Genomic Valley Biotech Ltd.

29 Jul 2025, 05:35PM

41.74

-7.41%

Board Meeting

Genomic Valley Biotech Ltd - 539206 - Board Meeting Intimation for Regulation 29 Of SEBI (Listing …

BSE India

Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia, to consider and approve the unaudited financial results (standalone) of the Company for the quarter ended on June 30, 2025.

Genomic Valley Biotech Ltd.

29 Jul 2025, 02:03PM

41.74

-7.41%

Company Update

Genomic Valley Biotech Ltd - 539206 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Certificate under Regulation 74 (5) of SEBI (DP) Regulation, 2018 for the quarter ended on 30th June, 2025.

Genomic Valley Biotech Ltd.

25 Jun 2025

41.74

-7.41%

SAST

Genomic Valley Biotech Ltd - 539206 - Closure of Trading Window

BSE India

Please find enclosed herewith Intimation for closure of trading window.

Genomic Valley Biotech Ltd.

13 Jun 2025

41.74

-7.41%

Result

Genomic Valley Biotech Ltd - 539206 - Finacial Results For Quarter And Financial Year Ended On …

BSE India

Financial results for Quarter and Financial Year ended on 31 March 2025.

Is Genomic Valley Biotech Ltd. worth buying?

5 Votes:

Buy 40.0%

Sell 40.0%

Hold 20.0%